trending Market Intelligence /marketintelligence/en/news-insights/trending/bW_xwdDbRkeBvuMqcKvs9A2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Cardinal Health fiscal Q4 profit up 6% YOY

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Cardinal Health fiscal Q4 profit up 6% YOY

Cardinal Health Inc. said its non-GAAP net earnings totaled $334.0 million, an increase of 6.0% from $315.0 million in the prior-year period.

Non-GAAP EPS for the fiscal fourth quarter ended June 30 came to $1.11, up 9.9% year over year from $1.01.

The S&P Global Market Intelligence consensus normalized EPS estimate for the quarter was 94 cents.

The Dublin, Ohio-based healthcare distributor's revenue grew 5.7% on an annual basis to $37.35 billion from $35.35 billion.

GAAP net earnings came to $194.0 million, or 65 cents per share, compared with a loss of $1.17 billion, or a loss of $3.76 per share, in the year-earlier period.

For the year, the company's non-GAAP net earnings totaled $5.28 per share, up from $5 per share in the prior year.

The S&P Global Market Intelligence consensus normalized EPS estimate for the full fiscal year was $5.16.

Non-GAAP net earnings were $1.59 billion, compared with $1.57 billion in the prior year.

Full-year revenue grew 6.4% year over year to $145.53 billion from $136.81 billion.

The company said GAAP net earnings rose 432.4% year over year to $1.36 billion, or $4.53 per share, in the full year, from $256.0 million, or 81 cents per share.

In reporting results, the company said it forecasts non-GAAP EPS in the range of $4.85 to $5.10 for the fiscal 2020 full year.

The S&P Global Market Intelligence consensus normalized EPS estimate for 2020 is $5.29.

Cardinal Health provides medical products and pharmaceuticals and solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices.